| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiology | 37 | 2018 | 468 | 8.550 |
Why?
|
| Heart Defects, Congenital | 74 | 2019 | 1799 | 6.140 |
Why?
|
| Pediatrics | 22 | 2016 | 1140 | 4.070 |
Why?
|
| Periodicals as Topic | 11 | 2018 | 187 | 3.570 |
Why?
|
| Biomedical Research | 12 | 2017 | 510 | 2.970 |
Why?
|
| Congresses as Topic | 7 | 2015 | 164 | 1.780 |
Why?
|
| Editorial Policies | 7 | 2017 | 50 | 1.550 |
Why?
|
| Cardiac Surgical Procedures | 11 | 2019 | 1099 | 1.440 |
Why?
|
| Continuity of Patient Care | 6 | 2014 | 154 | 1.380 |
Why?
|
| Societies, Medical | 6 | 2015 | 673 | 1.130 |
Why?
|
| Hyperlipoproteinemia Type II | 3 | 2019 | 84 | 1.080 |
Why?
|
| Fellowships and Scholarships | 4 | 2013 | 268 | 1.030 |
Why?
|
| Heart Diseases | 8 | 2015 | 482 | 1.000 |
Why?
|
| Education, Medical, Graduate | 7 | 2014 | 507 | 0.980 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2011 | 122 | 0.980 |
Why?
|
| Humans | 185 | 2019 | 122292 | 0.930 |
Why?
|
| Quality of Health Care | 4 | 2011 | 391 | 0.930 |
Why?
|
| Liver Transplantation | 3 | 2019 | 1033 | 0.910 |
Why?
|
| Cholesterol | 5 | 2014 | 521 | 0.860 |
Why?
|
| Cardiology Service, Hospital | 3 | 2014 | 15 | 0.840 |
Why?
|
| Dyslipidemias | 2 | 2018 | 227 | 0.840 |
Why?
|
| Lipids | 2 | 2018 | 512 | 0.820 |
Why?
|
| Life Style | 4 | 2018 | 394 | 0.810 |
Why?
|
| Cardiac Catheterization | 19 | 2019 | 631 | 0.780 |
Why?
|
| Mentors | 2 | 2014 | 145 | 0.770 |
Why?
|
| Career Choice | 3 | 2016 | 143 | 0.760 |
Why?
|
| Risk Reduction Behavior | 4 | 2016 | 132 | 0.750 |
Why?
|
| Education, Medical | 4 | 2014 | 285 | 0.750 |
Why?
|
| Thoracic Surgery | 2 | 2017 | 158 | 0.750 |
Why?
|
| Age Factors | 19 | 2019 | 2777 | 0.730 |
Why?
|
| Hospitals, Pediatric | 5 | 2018 | 776 | 0.710 |
Why?
|
| Heart Septal Defects, Atrial | 8 | 2011 | 122 | 0.660 |
Why?
|
| Internship and Residency | 4 | 2016 | 1153 | 0.640 |
Why?
|
| Education, Medical, Continuing | 2 | 2016 | 139 | 0.640 |
Why?
|
| Forecasting | 7 | 2018 | 355 | 0.620 |
Why?
|
| Hypercholesterolemia | 6 | 2012 | 226 | 0.600 |
Why?
|
| United States | 26 | 2018 | 10487 | 0.600 |
Why?
|
| Heart Septal Defects, Ventricular | 8 | 2011 | 133 | 0.590 |
Why?
|
| Access to Information | 2 | 2015 | 39 | 0.590 |
Why?
|
| Life Change Events | 1 | 2018 | 59 | 0.580 |
Why?
|
| Child | 63 | 2018 | 24063 | 0.580 |
Why?
|
| Adult | 77 | 2019 | 28730 | 0.550 |
Why?
|
| Transition to Adult Care | 2 | 2018 | 119 | 0.540 |
Why?
|
| Exercise Therapy | 1 | 2018 | 141 | 0.530 |
Why?
|
| Steroid Metabolism, Inborn Errors | 1 | 2015 | 3 | 0.520 |
Why?
|
| Cholic Acids | 1 | 2015 | 16 | 0.520 |
Why?
|
| Hyperlipidemias | 3 | 2016 | 174 | 0.520 |
Why?
|
| Specialization | 1 | 2016 | 76 | 0.510 |
Why?
|
| Wolman Disease | 1 | 2015 | 7 | 0.500 |
Why?
|
| Coronary Artery Disease | 2 | 2019 | 741 | 0.480 |
Why?
|
| Practice Guidelines as Topic | 4 | 2015 | 1244 | 0.470 |
Why?
|
| Health Services Accessibility | 3 | 2010 | 581 | 0.470 |
Why?
|
| History, 21st Century | 5 | 2017 | 270 | 0.460 |
Why?
|
| Publishing | 1 | 2015 | 104 | 0.460 |
Why?
|
| History, 20th Century | 5 | 2017 | 384 | 0.440 |
Why?
|
| Pediatric Obesity | 2 | 2016 | 366 | 0.420 |
Why?
|
| Personnel Staffing and Scheduling | 2 | 2013 | 78 | 0.420 |
Why?
|
| American Heart Association | 2 | 2013 | 288 | 0.420 |
Why?
|
| Preventive Health Services | 1 | 2013 | 53 | 0.410 |
Why?
|
| Workload | 2 | 2013 | 146 | 0.410 |
Why?
|
| Atrial Fibrillation | 2 | 2010 | 621 | 0.400 |
Why?
|
| Risk Factors | 19 | 2019 | 9901 | 0.400 |
Why?
|
| PubMed | 2 | 2010 | 21 | 0.400 |
Why?
|
| Electrocardiography | 18 | 2012 | 963 | 0.400 |
Why?
|
| Information Dissemination | 2 | 2011 | 184 | 0.400 |
Why?
|
| Marfan Syndrome | 6 | 2003 | 136 | 0.390 |
Why?
|
| Codes of Ethics | 1 | 2011 | 7 | 0.390 |
Why?
|
| Time Factors | 17 | 2019 | 6181 | 0.380 |
Why?
|
| Marketing of Health Services | 1 | 2011 | 25 | 0.380 |
Why?
|
| Journal Impact Factor | 3 | 2018 | 22 | 0.370 |
Why?
|
| Speech | 1 | 2011 | 53 | 0.370 |
Why?
|
| Pulmonary Artery | 9 | 2008 | 440 | 0.360 |
Why?
|
| Interdisciplinary Communication | 2 | 2011 | 134 | 0.360 |
Why?
|
| Cardiac Care Facilities | 1 | 2010 | 8 | 0.360 |
Why?
|
| Diffusion of Innovation | 3 | 2016 | 97 | 0.360 |
Why?
|
| Research Design | 1 | 2014 | 646 | 0.350 |
Why?
|
| Heart Aneurysm | 2 | 2010 | 38 | 0.350 |
Why?
|
| Adolescent | 56 | 2018 | 18939 | 0.350 |
Why?
|
| Advisory Committees | 1 | 2011 | 148 | 0.350 |
Why?
|
| Ambulatory Care | 2 | 2014 | 376 | 0.350 |
Why?
|
| Perinatal Care | 1 | 2010 | 68 | 0.340 |
Why?
|
| Critical Pathways | 1 | 2010 | 68 | 0.340 |
Why?
|
| Patient Care Management | 1 | 2010 | 65 | 0.340 |
Why?
|
| Coronary Vessels | 5 | 2013 | 525 | 0.340 |
Why?
|
| Mitral Valve | 4 | 2010 | 245 | 0.340 |
Why?
|
| Transposition of Great Vessels | 7 | 2005 | 131 | 0.340 |
Why?
|
| Noonan Syndrome | 1 | 2010 | 29 | 0.340 |
Why?
|
| Physicians | 1 | 2016 | 582 | 0.340 |
Why?
|
| Atrial Appendage | 1 | 2010 | 42 | 0.330 |
Why?
|
| Abnormalities, Multiple | 4 | 2013 | 962 | 0.330 |
Why?
|
| Child, Preschool | 47 | 2019 | 13777 | 0.330 |
Why?
|
| Community Health Services | 1 | 2010 | 90 | 0.330 |
Why?
|
| Patient Care Planning | 1 | 2010 | 122 | 0.330 |
Why?
|
| Death, Sudden | 3 | 2008 | 46 | 0.330 |
Why?
|
| Infant | 47 | 2015 | 12302 | 0.320 |
Why?
|
| Health Services Research | 1 | 2010 | 185 | 0.320 |
Why?
|
| Aortic Diseases | 3 | 2008 | 197 | 0.320 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2008 | 127 | 0.320 |
Why?
|
| Treatment Outcome | 15 | 2014 | 12043 | 0.320 |
Why?
|
| Risk Assessment | 6 | 2016 | 3307 | 0.300 |
Why?
|
| Cardiovascular Diseases | 5 | 2016 | 1822 | 0.300 |
Why?
|
| Central Nervous System Stimulants | 1 | 2008 | 124 | 0.290 |
Why?
|
| Follow-Up Studies | 26 | 2018 | 5013 | 0.290 |
Why?
|
| Palliative Care | 4 | 2008 | 424 | 0.290 |
Why?
|
| Female | 89 | 2019 | 64882 | 0.290 |
Why?
|
| Coronary Stenosis | 1 | 2008 | 70 | 0.290 |
Why?
|
| Receptors, LDL | 2 | 2019 | 90 | 0.290 |
Why?
|
| Coronary Disease | 7 | 1993 | 634 | 0.280 |
Why?
|
| Echocardiography | 21 | 2011 | 1066 | 0.280 |
Why?
|
| Mitral Valve Stenosis | 3 | 2005 | 34 | 0.280 |
Why?
|
| Male | 80 | 2019 | 59517 | 0.280 |
Why?
|
| Coronary Vessel Anomalies | 8 | 2013 | 268 | 0.280 |
Why?
|
| Angioplasty, Balloon | 1 | 2008 | 161 | 0.270 |
Why?
|
| Organizational Objectives | 3 | 2011 | 33 | 0.270 |
Why?
|
| Mass Screening | 2 | 2012 | 778 | 0.260 |
Why?
|
| Cooperative Behavior | 3 | 2012 | 217 | 0.260 |
Why?
|
| Angiography | 8 | 1988 | 214 | 0.260 |
Why?
|
| Catheterization | 2 | 2005 | 238 | 0.260 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2008 | 213 | 0.260 |
Why?
|
| Balloon Occlusion | 1 | 2005 | 43 | 0.250 |
Why?
|
| Prognosis | 10 | 2018 | 4488 | 0.250 |
Why?
|
| Hospitalization | 2 | 2012 | 1727 | 0.250 |
Why?
|
| Subtraction Technique | 12 | 1988 | 36 | 0.250 |
Why?
|
| HIV Infections | 12 | 2003 | 1858 | 0.240 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2005 | 42 | 0.240 |
Why?
|
| Young Adult | 11 | 2019 | 8759 | 0.230 |
Why?
|
| Heart Ventricles | 10 | 2016 | 767 | 0.230 |
Why?
|
| Sports Medicine | 1 | 2004 | 26 | 0.230 |
Why?
|
| Texas | 5 | 2019 | 3528 | 0.230 |
Why?
|
| Cardiomegaly | 5 | 2001 | 136 | 0.220 |
Why?
|
| Patient Care Team | 4 | 2011 | 539 | 0.220 |
Why?
|
| Cause of Death | 6 | 2019 | 451 | 0.220 |
Why?
|
| Physical Examination | 1 | 2004 | 163 | 0.220 |
Why?
|
| Biomarkers | 4 | 2014 | 2933 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 1204 | 0.210 |
Why?
|
| Hypertension, Pulmonary | 9 | 2011 | 428 | 0.200 |
Why?
|
| Predictive Value of Tests | 6 | 2014 | 2080 | 0.200 |
Why?
|
| Clinical Competence | 5 | 2014 | 972 | 0.200 |
Why?
|
| Survival Rate | 8 | 2016 | 1997 | 0.200 |
Why?
|
| Obesity | 1 | 2013 | 2083 | 0.200 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2004 | 244 | 0.200 |
Why?
|
| Glycogen Storage Disease Type II | 1 | 2001 | 10 | 0.200 |
Why?
|
| Stents | 1 | 2008 | 863 | 0.190 |
Why?
|
| Survivors | 2 | 2019 | 345 | 0.190 |
Why?
|
| Aortic Valve | 4 | 2000 | 426 | 0.190 |
Why?
|
| Interpersonal Relations | 2 | 2014 | 229 | 0.190 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2011 | 138 | 0.180 |
Why?
|
| Hemodynamics | 8 | 2009 | 838 | 0.170 |
Why?
|
| Comorbidity | 5 | 2019 | 1490 | 0.160 |
Why?
|
| Health Services Needs and Demand | 2 | 2005 | 171 | 0.160 |
Why?
|
| Heterotaxy Syndrome | 1 | 2019 | 62 | 0.160 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2011 | 647 | 0.160 |
Why?
|
| Infectious Disease Transmission, Vertical | 6 | 2003 | 237 | 0.160 |
Why?
|
| Hypertension, Renovascular | 2 | 2018 | 29 | 0.160 |
Why?
|
| Pregnancy Complications, Cardiovascular | 3 | 2006 | 103 | 0.150 |
Why?
|
| Arrhythmias, Cardiac | 6 | 2012 | 457 | 0.150 |
Why?
|
| Ventricular Function | 2 | 2018 | 93 | 0.150 |
Why?
|
| Renal Artery Obstruction | 2 | 2018 | 41 | 0.150 |
Why?
|
| Retrospective Studies | 22 | 2019 | 15853 | 0.150 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2003 | 107 | 0.140 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 2012 | 60 | 0.140 |
Why?
|
| Heart Failure | 6 | 2018 | 2125 | 0.140 |
Why?
|
| Patient Selection | 1 | 2000 | 685 | 0.140 |
Why?
|
| Health Status | 2 | 2019 | 370 | 0.140 |
Why?
|
| Infant, Newborn | 24 | 2005 | 8096 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2016 | 32 | 0.130 |
Why?
|
| Pedigree | 1 | 2019 | 1533 | 0.130 |
Why?
|
| Middle Aged | 35 | 2019 | 25636 | 0.130 |
Why?
|
| Pregnancy | 10 | 2010 | 7092 | 0.130 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2014 | 58 | 0.130 |
Why?
|
| Heart Block | 3 | 1992 | 41 | 0.130 |
Why?
|
| Curriculum | 2 | 2013 | 714 | 0.120 |
Why?
|
| Equipment Design | 2 | 2009 | 596 | 0.120 |
Why?
|
| Pulmonary Veins | 6 | 1989 | 163 | 0.120 |
Why?
|
| Attitude to Computers | 1 | 2015 | 49 | 0.120 |
Why?
|
| Interprofessional Relations | 3 | 2008 | 142 | 0.120 |
Why?
|
| Longitudinal Studies | 5 | 2014 | 1283 | 0.120 |
Why?
|
| Aorta, Thoracic | 4 | 2011 | 517 | 0.120 |
Why?
|
| Attitude of Health Personnel | 2 | 2012 | 635 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2016 | 3050 | 0.120 |
Why?
|
| Heart Valve Diseases | 4 | 1998 | 168 | 0.120 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2003 | 365 | 0.120 |
Why?
|
| Family Practice | 1 | 1994 | 89 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2012 | 815 | 0.110 |
Why?
|
| Peer Review | 1 | 2013 | 40 | 0.110 |
Why?
|
| Heart-Lung Transplantation | 1 | 1993 | 23 | 0.110 |
Why?
|
| Smoking | 2 | 2016 | 1028 | 0.110 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2005 | 241 | 0.110 |
Why?
|
| Health Resources | 1 | 2014 | 115 | 0.110 |
Why?
|
| Literature | 1 | 2012 | 6 | 0.100 |
Why?
|
| New Orleans | 1 | 2012 | 13 | 0.100 |
Why?
|
| Surveys and Questionnaires | 2 | 2018 | 3626 | 0.100 |
Why?
|
| Hospital Mortality | 3 | 2014 | 995 | 0.100 |
Why?
|
| Phenotype | 2 | 2014 | 4150 | 0.100 |
Why?
|
| Internet | 1 | 2015 | 373 | 0.100 |
Why?
|
| Homozygote | 1 | 2014 | 521 | 0.100 |
Why?
|
| Women's Health | 1 | 1993 | 129 | 0.100 |
Why?
|
| Heterozygote | 1 | 2014 | 675 | 0.100 |
Why?
|
| Takayasu Arteritis | 1 | 2011 | 13 | 0.100 |
Why?
|
| Travel | 1 | 2013 | 117 | 0.100 |
Why?
|
| Weight Gain | 1 | 2014 | 382 | 0.100 |
Why?
|
| Physician's Role | 2 | 2009 | 162 | 0.100 |
Why?
|
| Ventricular Function, Left | 3 | 2001 | 500 | 0.100 |
Why?
|
| Cyclonic Storms | 1 | 2012 | 76 | 0.100 |
Why?
|
| Global Health | 1 | 2016 | 555 | 0.090 |
Why?
|
| Disasters | 1 | 2012 | 99 | 0.090 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2012 | 73 | 0.090 |
Why?
|
| Patient Admission | 2 | 2011 | 184 | 0.090 |
Why?
|
| Warfarin | 1 | 2012 | 119 | 0.090 |
Why?
|
| Diagnostic Imaging | 1 | 2013 | 269 | 0.090 |
Why?
|
| Aged | 18 | 2014 | 18783 | 0.090 |
Why?
|
| Hospital Planning | 1 | 2010 | 3 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 3301 | 0.090 |
Why?
|
| North America | 1 | 2011 | 234 | 0.090 |
Why?
|
| Hypertension | 2 | 2016 | 1274 | 0.090 |
Why?
|
| DNA | 1 | 2015 | 1606 | 0.090 |
Why?
|
| Hypertension, Portal | 1 | 1991 | 80 | 0.090 |
Why?
|
| Health Care Rationing | 1 | 2010 | 58 | 0.090 |
Why?
|
| Health Care Reform | 1 | 2010 | 50 | 0.090 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2011 | 425 | 0.090 |
Why?
|
| Endovascular Procedures | 1 | 2018 | 710 | 0.080 |
Why?
|
| Aortic Valve Stenosis | 2 | 1997 | 322 | 0.080 |
Why?
|
| Anticoagulants | 2 | 2012 | 582 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2014 | 711 | 0.080 |
Why?
|
| Canada | 1 | 2010 | 294 | 0.080 |
Why?
|
| Lung Transplantation | 1 | 1993 | 316 | 0.080 |
Why?
|
| Heart Valve Prosthesis | 1 | 1992 | 293 | 0.080 |
Why?
|
| Program Development | 1 | 2010 | 189 | 0.080 |
Why?
|
| Family Relations | 1 | 2009 | 69 | 0.080 |
Why?
|
| Angiocardiography | 5 | 1986 | 13 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 1630 | 0.080 |
Why?
|
| MEDLINE | 1 | 2008 | 20 | 0.080 |
Why?
|
| Myxoma | 2 | 1988 | 29 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2014 | 1463 | 0.080 |
Why?
|
| Genotype | 2 | 2016 | 2525 | 0.080 |
Why?
|
| Coronary Restenosis | 1 | 2008 | 20 | 0.080 |
Why?
|
| Triglycerides | 1 | 1991 | 560 | 0.080 |
Why?
|
| Long-Term Care | 2 | 2008 | 71 | 0.080 |
Why?
|
| Ventricular Remodeling | 1 | 2009 | 175 | 0.080 |
Why?
|
| Radiography | 10 | 1993 | 804 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2014 | 978 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 792 | 0.070 |
Why?
|
| Heart Neoplasms | 2 | 1988 | 103 | 0.070 |
Why?
|
| Vascular Patency | 1 | 2008 | 202 | 0.070 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2008 | 172 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2018 | 2817 | 0.070 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2009 | 276 | 0.070 |
Why?
|
| Heart Transplantation | 1 | 1993 | 853 | 0.070 |
Why?
|
| Device Removal | 1 | 2008 | 223 | 0.070 |
Why?
|
| Prenatal Diagnosis | 1 | 2010 | 580 | 0.070 |
Why?
|
| Equipment Safety | 1 | 2005 | 37 | 0.060 |
Why?
|
| Heart | 5 | 1989 | 723 | 0.060 |
Why?
|
| Postoperative Complications | 4 | 1995 | 2996 | 0.060 |
Why?
|
| Diagnosis, Differential | 5 | 2001 | 1871 | 0.060 |
Why?
|
| Ultrasonography | 2 | 2012 | 941 | 0.060 |
Why?
|
| Prosthesis Design | 1 | 2008 | 664 | 0.060 |
Why?
|
| Down Syndrome | 3 | 2011 | 194 | 0.060 |
Why?
|
| Rhabdomyoma | 1 | 1984 | 16 | 0.060 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 438 | 0.060 |
Why?
|
| Prosthesis Implantation | 1 | 2005 | 144 | 0.060 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2005 | 87 | 0.060 |
Why?
|
| Thorax | 1 | 1984 | 73 | 0.060 |
Why?
|
| Prospective Studies | 8 | 2018 | 5962 | 0.060 |
Why?
|
| Safety | 1 | 2004 | 217 | 0.060 |
Why?
|
| Mitral Valve Prolapse | 2 | 1990 | 28 | 0.050 |
Why?
|
| Prevalence | 6 | 2012 | 2371 | 0.050 |
Why?
|
| Animals | 2 | 2015 | 33723 | 0.050 |
Why?
|
| Anorexia Nervosa | 1 | 1983 | 24 | 0.050 |
Why?
|
| Survival Analysis | 4 | 2000 | 1468 | 0.050 |
Why?
|
| Cholesterol, LDL | 3 | 1991 | 554 | 0.050 |
Why?
|
| Cardiac Output | 2 | 1981 | 169 | 0.050 |
Why?
|
| Aneurysm | 2 | 1986 | 89 | 0.050 |
Why?
|
| Referral and Consultation | 3 | 2014 | 525 | 0.050 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2002 | 51 | 0.050 |
Why?
|
| Mutation | 1 | 2015 | 5734 | 0.050 |
Why?
|
| Double Outlet Right Ventricle | 1 | 2001 | 21 | 0.050 |
Why?
|
| Pulmonary Valve | 2 | 1980 | 98 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2001 | 400 | 0.050 |
Why?
|
| Tetralogy of Fallot | 4 | 1986 | 160 | 0.050 |
Why?
|
| Pain | 1 | 1984 | 450 | 0.050 |
Why?
|
| Thallium | 1 | 1980 | 9 | 0.050 |
Why?
|
| Zidovudine | 1 | 2000 | 22 | 0.050 |
Why?
|
| Coronary Circulation | 1 | 2001 | 208 | 0.040 |
Why?
|
| Linear Models | 2 | 2012 | 657 | 0.040 |
Why?
|
| Sinus of Valsalva | 1 | 1980 | 36 | 0.040 |
Why?
|
| Thermodilution | 1 | 1979 | 10 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2000 | 262 | 0.040 |
Why?
|
| Tolazoline | 1 | 1979 | 1 | 0.040 |
Why?
|
| Fetal Heart | 1 | 2000 | 111 | 0.040 |
Why?
|
| Echocardiography, Doppler | 1 | 2000 | 171 | 0.040 |
Why?
|
| Career Mobility | 1 | 2000 | 51 | 0.040 |
Why?
|
| Disease Progression | 3 | 2019 | 1990 | 0.040 |
Why?
|
| Pulmonary Circulation | 2 | 1979 | 120 | 0.040 |
Why?
|
| Job Satisfaction | 1 | 2000 | 77 | 0.040 |
Why?
|
| Physicians, Women | 1 | 2000 | 46 | 0.040 |
Why?
|
| Mediastinal Diseases | 1 | 1999 | 15 | 0.040 |
Why?
|
| Radionuclide Imaging | 5 | 1984 | 151 | 0.040 |
Why?
|
| Vasoconstriction | 1 | 1979 | 103 | 0.040 |
Why?
|
| Corneal Opacity | 1 | 1998 | 23 | 0.040 |
Why?
|
| Gaucher Disease | 1 | 1998 | 12 | 0.040 |
Why?
|
| Aortic Aneurysm | 3 | 1989 | 224 | 0.040 |
Why?
|
| HIV-1 | 1 | 2002 | 463 | 0.040 |
Why?
|
| Cholesterol, HDL | 2 | 1991 | 347 | 0.040 |
Why?
|
| Cohort Studies | 5 | 2016 | 4643 | 0.040 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2011 | 783 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 3448 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 1407 | 0.040 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2000 | 226 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2004 | 748 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2000 | 440 | 0.040 |
Why?
|
| Anti-HIV Agents | 1 | 2000 | 304 | 0.040 |
Why?
|
| Incidence | 4 | 2012 | 3018 | 0.040 |
Why?
|
| Surgical Wound Infection | 1 | 1999 | 257 | 0.030 |
Why?
|
| Turner Syndrome | 1 | 1997 | 46 | 0.030 |
Why?
|
| Coronary Angiography | 4 | 2001 | 417 | 0.030 |
Why?
|
| Endocarditis, Bacterial | 2 | 1988 | 129 | 0.030 |
Why?
|
| Length of Stay | 2 | 2012 | 1272 | 0.030 |
Why?
|
| Pacemaker, Artificial | 2 | 1992 | 170 | 0.030 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 1999 | 251 | 0.030 |
Why?
|
| Morbidity | 1 | 2016 | 239 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2000 | 901 | 0.030 |
Why?
|
| Pericarditis | 2 | 1986 | 41 | 0.030 |
Why?
|
| Heart Septal Defects | 2 | 1985 | 40 | 0.030 |
Why?
|
| Competitive Behavior | 1 | 2014 | 10 | 0.030 |
Why?
|
| Preventive Medicine | 1 | 1994 | 22 | 0.030 |
Why?
|
| Autopsy | 2 | 1991 | 114 | 0.030 |
Why?
|
| Fetal Death | 1 | 1995 | 115 | 0.030 |
Why?
|
| Digoxin | 2 | 1987 | 43 | 0.030 |
Why?
|
| Health Services | 1 | 1994 | 71 | 0.030 |
Why?
|
| Medically Underserved Area | 1 | 1994 | 87 | 0.030 |
Why?
|
| Sports | 1 | 2014 | 59 | 0.030 |
Why?
|
| Actuarial Analysis | 1 | 1993 | 31 | 0.030 |
Why?
|
| Contraceptives, Oral | 1 | 1993 | 39 | 0.030 |
Why?
|
| Trachea | 2 | 1993 | 197 | 0.030 |
Why?
|
| Syndrome | 4 | 1983 | 1109 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 1998 | 503 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2016 | 1067 | 0.030 |
Why?
|
| Pulmonary Valve Stenosis | 3 | 1984 | 41 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 1994 | 117 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 231 | 0.030 |
Why?
|
| Aorta | 1 | 1976 | 533 | 0.030 |
Why?
|
| Internal Medicine | 1 | 1994 | 147 | 0.030 |
Why?
|
| Pneumococcal Infections | 1 | 1975 | 274 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 1994 | 297 | 0.030 |
Why?
|
| Mortality | 2 | 1984 | 221 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 2 | 1985 | 259 | 0.030 |
Why?
|
| International Normalized Ratio | 1 | 2012 | 42 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 1993 | 197 | 0.020 |
Why?
|
| Heart Septum | 2 | 1984 | 57 | 0.020 |
Why?
|
| Thromboembolism | 1 | 1992 | 84 | 0.020 |
Why?
|
| Polyarteritis Nodosa | 1 | 1991 | 7 | 0.020 |
Why?
|
| Prosthesis Failure | 1 | 1992 | 156 | 0.020 |
Why?
|
| Endocarditis | 1 | 1992 | 103 | 0.020 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1991 | 40 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 421 | 0.020 |
Why?
|
| Faculty, Medical | 1 | 2014 | 262 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2011 | 169 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 2797 | 0.020 |
Why?
|
| Diatrizoate Meglumine | 3 | 1986 | 18 | 0.020 |
Why?
|
| Heart Atria | 4 | 1984 | 307 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1004 | 0.020 |
Why?
|
| Catheterization, Central Venous | 1 | 1991 | 131 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2012 | 381 | 0.020 |
Why?
|
| Cysts | 1 | 1990 | 99 | 0.020 |
Why?
|
| Ebstein Anomaly | 1 | 1989 | 26 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2012 | 376 | 0.020 |
Why?
|
| Calcinosis | 3 | 1998 | 167 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 1234 | 0.020 |
Why?
|
| Aortic Coarctation | 2 | 1997 | 105 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 1989 | 151 | 0.020 |
Why?
|
| Hodgkin Disease | 1 | 1991 | 293 | 0.020 |
Why?
|
| Haemophilus Infections | 1 | 1988 | 92 | 0.020 |
Why?
|
| Lovastatin | 1 | 1988 | 25 | 0.020 |
Why?
|
| Vena Cava, Superior | 2 | 1985 | 55 | 0.020 |
Why?
|
| Syncope | 1 | 1987 | 52 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2573 | 0.020 |
Why?
|
| Puerperal Disorders | 1 | 1987 | 46 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 1989 | 239 | 0.020 |
Why?
|
| Scimitar Syndrome | 1 | 1987 | 52 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2014 | 1060 | 0.020 |
Why?
|
| Thrombosis | 1 | 1991 | 515 | 0.020 |
Why?
|
| Computers | 2 | 1986 | 66 | 0.020 |
Why?
|
| Salmonella Infections | 1 | 1986 | 31 | 0.020 |
Why?
|
| Diuretics | 1 | 1987 | 158 | 0.020 |
Why?
|
| Renal Artery | 1 | 1986 | 73 | 0.020 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1987 | 218 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1987 | 234 | 0.020 |
Why?
|
| Endocarditis, Subacute Bacterial | 1 | 1985 | 1 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1987 | 570 | 0.020 |
Why?
|
| Phlebography | 1 | 1985 | 51 | 0.020 |
Why?
|
| Diatrizoate | 1 | 1984 | 3 | 0.020 |
Why?
|
| Exercise Test | 2 | 1983 | 247 | 0.020 |
Why?
|
| Tricuspid Valve | 1 | 1985 | 61 | 0.010 |
Why?
|
| Radiography, Thoracic | 2 | 1983 | 156 | 0.010 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1986 | 142 | 0.010 |
Why?
|
| Technetium | 2 | 1984 | 13 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1984 | 254 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 1991 | 825 | 0.010 |
Why?
|
| Sepsis | 1 | 1988 | 472 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1985 | 287 | 0.010 |
Why?
|
| Space-Time Clustering | 1 | 1983 | 1 | 0.010 |
Why?
|
| Telephone | 1 | 1984 | 109 | 0.010 |
Why?
|
| Diet | 1 | 1990 | 1106 | 0.010 |
Why?
|
| Ear, External | 1 | 1983 | 22 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1984 | 266 | 0.010 |
Why?
|
| Ohio | 1 | 1983 | 88 | 0.010 |
Why?
|
| Lens Subluxation | 1 | 2003 | 4 | 0.010 |
Why?
|
| Postoperative Period | 2 | 1986 | 330 | 0.010 |
Why?
|
| Postoperative Care | 2 | 1986 | 291 | 0.010 |
Why?
|
| Micrognathism | 1 | 1983 | 64 | 0.010 |
Why?
|
| Situs Inversus | 2 | 1979 | 26 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 845 | 0.010 |
Why?
|
| Life Tables | 1 | 2002 | 28 | 0.010 |
Why?
|
| Heart Rate | 2 | 2002 | 584 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 1987 | 475 | 0.010 |
Why?
|
| Organ Size | 1 | 2003 | 411 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 1982 | 68 | 0.010 |
Why?
|
| Seasons | 1 | 1983 | 300 | 0.010 |
Why?
|
| Cardiac Volume | 1 | 2001 | 17 | 0.010 |
Why?
|
| Preoperative Care | 2 | 1986 | 350 | 0.010 |
Why?
|
| Cleft Palate | 1 | 1983 | 138 | 0.010 |
Why?
|
| Fistula | 1 | 1982 | 50 | 0.010 |
Why?
|
| Contrast Media | 1 | 1985 | 459 | 0.010 |
Why?
|
| ROC Curve | 1 | 2003 | 552 | 0.010 |
Why?
|
| Prostaglandins E | 1 | 1981 | 8 | 0.010 |
Why?
|
| Furosemide | 1 | 1981 | 36 | 0.010 |
Why?
|
| Alprostadil | 1 | 1981 | 27 | 0.010 |
Why?
|
| Radioisotopes | 1 | 1980 | 38 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2002 | 755 | 0.010 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 1980 | 13 | 0.010 |
Why?
|
| Collateral Circulation | 1 | 1980 | 45 | 0.010 |
Why?
|
| Physical Exertion | 1 | 1980 | 80 | 0.010 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 1982 | 89 | 0.010 |
Why?
|
| Microcephaly | 1 | 1983 | 312 | 0.010 |
Why?
|
| Observer Variation | 1 | 2001 | 297 | 0.010 |
Why?
|
| Mitochondria, Heart | 1 | 2000 | 60 | 0.010 |
Why?
|
| Risk | 1 | 2002 | 744 | 0.010 |
Why?
|
| Saphenous Vein | 1 | 1980 | 53 | 0.010 |
Why?
|
| HIV Antibodies | 1 | 2000 | 69 | 0.010 |
Why?
|
| Pericardium | 1 | 1981 | 83 | 0.010 |
Why?
|
| Pyridoxal | 1 | 1979 | 1 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1980 | 300 | 0.010 |
Why?
|
| Glutamates | 1 | 1979 | 69 | 0.010 |
Why?
|
| HIV | 1 | 2000 | 179 | 0.010 |
Why?
|
| Tachycardia, Paroxysmal | 1 | 1979 | 10 | 0.010 |
Why?
|
| Diving | 1 | 1979 | 3 | 0.010 |
Why?
|
| Tachycardia | 1 | 1999 | 67 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2000 | 261 | 0.010 |
Why?
|
| Maternal Exposure | 1 | 2000 | 148 | 0.010 |
Why?
|
| Sternum | 1 | 1999 | 53 | 0.010 |
Why?
|
| Pericardial Effusion | 1 | 1999 | 64 | 0.010 |
Why?
|
| Hypoxia | 1 | 1981 | 246 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2000 | 448 | 0.010 |
Why?
|
| Debridement | 1 | 1999 | 84 | 0.010 |
Why?
|
| Spleen | 1 | 1979 | 283 | 0.010 |
Why?
|
| AIDS Dementia Complex | 1 | 1998 | 12 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 2010 | 0.010 |
Why?
|
| Corneal Stroma | 1 | 1998 | 90 | 0.010 |
Why?
|
| Myocardium | 1 | 2003 | 980 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1998 | 230 | 0.010 |
Why?
|
| Prenatal Care | 1 | 2000 | 340 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2000 | 592 | 0.010 |
Why?
|
| Diet, Fat-Restricted | 1 | 1997 | 39 | 0.010 |
Why?
|
| Health Maintenance Organizations | 1 | 1997 | 20 | 0.010 |
Why?
|
| Polyethylene Terephthalates | 1 | 1976 | 40 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 1984 | 994 | 0.010 |
Why?
|
| Heart Sounds | 1 | 1976 | 9 | 0.010 |
Why?
|
| Gestational Age | 1 | 2000 | 1115 | 0.010 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 1997 | 170 | 0.010 |
Why?
|
| Kanamycin | 1 | 1975 | 6 | 0.010 |
Why?
|
| Nafcillin | 1 | 1975 | 14 | 0.010 |
Why?
|
| Penicillin G | 1 | 1975 | 19 | 0.010 |
Why?
|
| Lung Diseases | 1 | 1979 | 384 | 0.010 |
Why?
|
| Rupture, Spontaneous | 1 | 1975 | 48 | 0.010 |
Why?
|
| Counseling | 1 | 1997 | 218 | 0.010 |
Why?
|
| Glucose | 1 | 1979 | 875 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1976 | 659 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 1988 | 1147 | 0.010 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1976 | 521 | 0.010 |
Why?
|
| Heart Murmurs | 1 | 1990 | 15 | 0.010 |
Why?
|
| Heart Valves | 1 | 1990 | 52 | 0.010 |
Why?
|
| Necrosis | 1 | 1990 | 212 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 1989 | 93 | 0.010 |
Why?
|
| Emergencies | 1 | 1990 | 175 | 0.010 |
Why?
|
| Colestipol | 1 | 1988 | 6 | 0.000 |
Why?
|
| Stroke Volume | 1 | 1989 | 446 | 0.000 |
Why?
|
| Methods | 2 | 1977 | 150 | 0.000 |
Why?
|
| Diagnostic Errors | 1 | 1991 | 318 | 0.000 |
Why?
|
| Aortic Arch Syndromes | 1 | 1986 | 12 | 0.000 |
Why?
|
| Manometry | 1 | 1986 | 47 | 0.000 |
Why?
|
| Salmonella typhimurium | 1 | 1986 | 41 | 0.000 |
Why?
|
| Renal Veins | 1 | 1986 | 35 | 0.000 |
Why?
|
| Esophagoscopy | 1 | 1986 | 150 | 0.000 |
Why?
|
| Esophagus | 1 | 1986 | 207 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 1987 | 492 | 0.000 |
Why?
|
| Rheumatic Heart Disease | 1 | 1985 | 37 | 0.000 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1986 | 168 | 0.000 |
Why?
|
| Premedication | 1 | 1983 | 44 | 0.000 |
Why?
|
| Heart Function Tests | 1 | 1983 | 57 | 0.000 |
Why?
|
| Bundle of His | 1 | 1982 | 8 | 0.000 |
Why?
|
| Diseases in Twins | 1 | 1982 | 93 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1985 | 1247 | 0.000 |
Why?
|
| Gallbladder | 1 | 1979 | 19 | 0.000 |
Why?
|
| Truncus Arteriosus | 1 | 1979 | 14 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1985 | 2030 | 0.000 |
Why?
|
| Minnesota | 1 | 1977 | 130 | 0.000 |
Why?
|
| Pressure | 1 | 1977 | 128 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1985 | 2385 | 0.000 |
Why?
|
| Liver | 1 | 1979 | 1851 | 0.000 |
Why?
|